Trial · NCT01644331
Registered outcomes14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 14 of 14
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Dyspnea Improvement Measured by Likert Scale at 8 and 24 Hours | 8 and 24 hours | The number of patients with at least moderate improvement (as reported by patient) in dyspnea Likert scale at both 8 AND 24 hours AND without the need for escalation of therapy due to worsening heart failure (rescue therapy) or death within 24 hours. |
| Secondary | Renal Function | 0, 24, 48 and 72 hours | Change in Serum creatinine from baseline to 24, 48 and 72 hours |
| Secondary | Weight Loss | 0, 24, 48, and 72 hours | Change in body weight from baseline to 24, 48, and 72 hours |
| Secondary | Fluid Loss | 0, 24, 48, and 72 hours | Change from baseline fluid balance at 24, 48, and 72 hours |
| Secondary | Dyspnea Likert | 48 and 72 hours | Number of patients that experience moderate or greater improvement (patient reported) in dyspnea by 7 point Likert scale at 48 and 72 hours |
| Secondary | Hospital Stay | 7 days | Total days spent in hospital from baseline until discharge or death |
| Secondary | Worsening or Persistent Heart Failure or Death | 72 hrs | Number of patients with worsening heart failure or death |
| Secondary | Over-diuresis | 72 hours | clinical evidence of volume depletion requiring intervention other than holding diuretics during the 72 hours after randomization |
| Secondary | Serum Sodium | 0, 24, 48, and 72 hours | Change in serum sodium from baseline to 24, 48, and 72 hours |
| Secondary | Dyspnea 11 Point NRS | 0, 24, 48, and 72 hours | Change in NRS for assessment of dyspnea from baseline to 24, 48, and 72 hours (scale ranges from 0-No difficulty breathing to 10-Difficulty as bad as you can imagine) |
| Secondary | Freedom From Congestion | 24, 48, and 72 hours | Jugular Venous Pressure (JVP) \< 8 cm, no orthopnea, trace peripheral edema or less, and will be assessed at 24, 48, and 72 hours |
| Secondary | Development of Worsening Renal Function | 72 hours | increase in serum creatinine ≥ 0.3mg/dl from randomization at any time point during 72 hours after randomization |
| Secondary | Days Hospitalized or Deceased | 30 days | Total days hospitalized or deceased during the 30 days after randomization |
| Secondary | All Cause Death or Rehospitalization | 30 days | All cause death or rehospitalization (to include unscheduled clinic visits or ED visits) at 30 days (Kaplan-Meier and 95% confidence interval) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01644331/registered